Example: Heart Attack

Search clinical trials for: Machine learning algorithm

Total 10000 results

NCT04533061

Completed

Influenza Vaccine in Lung Transplant Patients - T Cells

Influenza
NCT04533139

Completed

Influenza Vaccine in Lung Transplant Patients - Antibody

Influenza
NCT04579822

Unknown

Maternal and Fetal Outcomes Following Influenza Vaccination in Pregnancy

Pregnancy Related | Influenza Virus Vaccine Adverse Reaction
NCT00307541

Completed

Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Streptococcus Pneumoniae Vaccines | Infections, Streptococcal
NCT04123119

Completed

Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model

Diarrhoeal Disease
NCT03038711

Completed

A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers

Ulcerative Colitis
NCT02848326

Completed

Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention

Migraine, With or Without Aura
NCT01651949

Completed

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)

Anal Cancer | Genital Warts | Anal Intraepithelial Neoplasia
NCT02215707

Completed

A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses

Malaria
NCT02956551

Unknown

Personalized DC Vaccine for Lung Cancer (SKLB1608)

Carcinoma, Non-Small-Cell Lung
NCT03004040

Unknown

Protection From Influenza: Determining the Impact of Prior Infection

Influenza
NCT03170765

Unknown

Randomized Controlled Trial of Measles Vaccination Schedule

MEASLES DISEASE
NCT00140686

Completed

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

Infections, Rotavirus
NCT00169481

Completed

A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine

Streptococcal Infections
NCT00307567

Completed

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b
NCT00196963

Completed

Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Infections, Meningococcal
NCT00346892

Completed

To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV

Rotavirus Infections
NCT01177202

Completed

Study of the Safety and Immunogenicity of H1N1 Vaccine

H1N1 Flu
NCT01827917

Completed

The Protection Effect of Speeda® Rabies Vaccine for Human Use

Rabies Vaccine Allergy
NCT00214071

Completed

Immunological Consequences of Obstructive Sleep Apnea

Obstructive Sleep Apnea
NCT01761435

Completed

Clinical Trial Evaluating Efficacy and Safety of One Dose Versus Two Doses of Influenza Vaccination (TraNsgripe)

Infection in Solid Organ Transplant Recipients
NCT00012727

Completed

Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment

Dual Diagnosis
NCT01195844

Terminated

Gastroenteritis From Rotavirus Infection in Brazilian Children Less Than 5 Years of Age (Study V260-031).

Pediatric Gastroenteritis
NCT01658800

Completed

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49

Influenza
NCT01830283

Unknown

The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination

Varicella
NCT01763268

Unknown

Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants

Immunogenicity | Reactogenicity
NCT00918268

Completed

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects

Influenza Disease
NCT00345319

Completed

Purified Rabies Vaccine for Human Use (Chick-embryo Cell)

Rabies Post-exposure Prophylaxis
NCT00187044

Completed

Evaluation of the Safety of a Polyvalent Virus in Healthy Adults

HIV Infection | Human Immunodeficiency Virus
NCT00097396

Completed

Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V

Pneumonic Plague | Preventive Therapy
NCT01002508

Unknown

Influenza Vaccination in Patients With Scleroderma

Influenza Vaccine in Scleroderma
NCT00310648

Completed

Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)

Influenza
NCT00327496

Unknown

Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells

Carcinoma, Hepatocellular
NCT00103467

Completed

Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine

Prevention of Anthrax Infection
NCT00000915

Completed

An HIV Vaccine Preparedness Study

HIV Infections
NCT04080531

Completed

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

Plasma Cell Neoplasm
NCT05553301

Completed

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older

Influenza Immunization
NCT01006798

Completed

Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

Influenza | Bird Flu
NCT02559921

Completed

Safety and Immunogenicity Study of Recombinant Human Rabies Immunoglobin (rhRIG) in Combination With Rabies Vaccine for Human Use With Human Rabies Immune Globulin (HRIG) in Combination With Rabies Vaccine for Human Use in Healthy Adult Subjects.

Rabies
NCT02488486

Terminated

Postoperative Sedation After Cardiac Surgery (SEDCAR)

Anesthesia | Surgery, Cardiac
NCT00849680

Completed

A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)

HIV Infections | HIV-1
NCT03981952

Completed

Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine

Risk Reduction
NCT00310804

Completed

Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60)

Influenza
NCT06110377

Recruiting

MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine) (MMP)

Androgenic Alopecia
NCT03124641

Completed

HOPE for Human Extended Criteria and Donation After Brain Death Donor (ECD-DBD) Liver Allografts (HOPE-ECD-DBD)

Liver Transplant | Hepatocellular Injury
NCT01529606

Completed

Cold Plasma for Dental Restoration and Caries Prevention

Caries | Dental Restoration
NCT03354728

Recruiting

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant

Hematopoietic Cell Transplant Recipient | Cytomegaloviral Infection
NCT06524414

Active, not recruiting

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants

Pneumococcal Disease
NCT00622843

Completed

Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting

HIV Infections | Streptococcus Pneumoniae
NCT00194714

Completed

Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab

Stage IV Breast Cancer | HER2/Neu Positive | HLA-A2 Positive Cells Present | Stage IV Ovarian Cancer

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations